Free cash flow CAGR uses the stored cash-flow statement history.
Over the past 12 months, Free Cash Flow CAGR is -7.69%.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Free cash flow CAGR measures how the company's cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.
Medline Inc. (MDLN)
Free Cash Flow growth vs the same quarter one year earlier, last 2 quarters.
Reported quarterly free cash flow; no daily interpolation.
| Year | Start FCF | End FCF | Change | % Change |
|---|---|---|---|---|
| 2025 | $1.41B | $1.30B | −$108.00M | -7.69% |
| 2024 | $1.40B | $1.41B | +$5.00M | +0.36% |
| 2023 | −$67.00M | $1.40B | +$1.47B | N/A |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Quarter ended Mar 2026 | $316.00M | -44.7% | -40.9% |
| Quarter ended Dec 2025 | $571.00M | +6.7% | -7.2% |
| Quarter ended Sep 2025 | $535.00M | +419.4% | N/A |
| Quarter ended Jun 2025 | $103.00M | -80.7% | N/A |
| Quarter ended Mar 2025 | $535.00M | -13.0% | N/A |
| Quarter ended Sep 2024 | $615.00M | N/A | N/A |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
